718 related articles for article (PubMed ID: 25962197)
21. Management of multi-drug resistant tuberculosis: practitioner's view point.
Prasad R
Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of acquired MDR-TB and HIV co-infection.
Deivanayagam CN; Rajasekaran S; Venkatesan R; Mahilmaran A; Ahmed PR; Annadurai S; Kumar S; Chandrasekar C; Ravichandran N; Pencillaiah R
Indian J Chest Dis Allied Sci; 2002; 44(4):237-42. PubMed ID: 12437236
[TBL] [Abstract][Full Text] [Related]
23. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
Chang KC; Yew WW
Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
[TBL] [Abstract][Full Text] [Related]
24. The making of a public health problem: multi-drug resistant tuberculosis in India.
Engel NC
Health Policy Plan; 2013 Jul; 28(4):375-85. PubMed ID: 22865835
[TBL] [Abstract][Full Text] [Related]
25. [Multidrug-resistant tuberculosis].
Alcaide F; Santín M
Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():54-60. PubMed ID: 19100168
[TBL] [Abstract][Full Text] [Related]
26. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
[TBL] [Abstract][Full Text] [Related]
27. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
28. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
[TBL] [Abstract][Full Text] [Related]
29. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
[TBL] [Abstract][Full Text] [Related]
30. Management of Multidrug-Resistant Tuberculosis.
Daley CL; Caminero JA
Semin Respir Crit Care Med; 2018 Jun; 39(3):310-324. PubMed ID: 30071546
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
Ahmad S; Mokaddas E
Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
[TBL] [Abstract][Full Text] [Related]
32. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
[TBL] [Abstract][Full Text] [Related]
33. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.
Abate G
Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570
[TBL] [Abstract][Full Text] [Related]
34. Drug-resistant tuberculosis in Cuba. Results of the three global projects.
Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA
Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512
[TBL] [Abstract][Full Text] [Related]
35. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of drug-resistant tuberculosis: world--Europe--Poland].
Jagielski T; Augustynowicz-Kopeć E; Zwolska Z
Wiad Lek; 2010; 63(4):345-57. PubMed ID: 21612049
[TBL] [Abstract][Full Text] [Related]
37. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
Fears R; Kaufmann S; Ter Meulen V; Zumla A;
Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
[TBL] [Abstract][Full Text] [Related]
38. Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
Nourzad S; Jenkins HE; Milstein M; Mitnick CD
Int J Tuberc Lung Dis; 2017 Jan; 21(1):6-11. PubMed ID: 28157458
[TBL] [Abstract][Full Text] [Related]
39. Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey.
Espinal MA; Báez J; Soriano G; Garcia V; Laszlo A; Reingold AL; Sanchez S
Int J Tuberc Lung Dis; 1998 Jun; 2(6):490-8. PubMed ID: 9626607
[TBL] [Abstract][Full Text] [Related]
40. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
